World's Best Scientists 2026 revealed!

Overview

Laurence Meyer is affiliated with the University of Utah in the United States and has contributed to research primarily within the field of Medicine, with a particular focus on Pharmacology, Biological Psychiatry, Psychiatry and Mental Health, Public Health, Environmental and Occupational Health, and Molecular Biology.

The scientist's recent publications include studies addressing pharmacogenomic testing and its impact on medication selection and symptom remission in major depressive disorder, published in 2022 in JAMA. Additionally, they contributed to research related to the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program, published in 2021 in Pharmacogenomics.

  • Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder, 2022, JAMA
  • Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program, 2021, Pharmacogenomics

Their frequent co-authors include:

  • Michael Icardi
  • Jason L. Vassy
  • Deepak Voora
  • David W. Oslin
  • Kevin G. Lynch

Laurence Meyer's published work appears frequently in journals such as JAMA and Pharmacogenomics.

  • JAMA
  • Pharmacogenomics

The scientist's research covers several main topics, including:

  • Treatment of Major Depression
  • Tryptophan and brain disorders
  • Bipolar Disorder and Treatment
  • Pharmacogenetics and Drug Metabolism
  • Ethics in Clinical Research
  • Metabolomics and Mass Spectrometry Studies

Best Publications

  • Analysis of the p16 gene (CDKN2) as a candidate· for the chromosome 9p melanoma susceptibility locus

    A. Kamb;D. Shattuck-Eidens;R. Eeles;R. Eeles;Qingyun Liu

  • Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22.

    Lisa A. Cannon-Albright;David E. Goldgar;Laurence J. Meyer;Cathryn M. Lewis

  • Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis

    A Babiker;S Darby;D De Angelis;D Kwart

  • The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

    Maile Ray;Roger Logan;Jonathan A C Sterne;Sonia Hernández-Díaz

  • Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis.

    J J Zone;T B Taylor;D P Kadunce;L J Meyer

  • HIV-1 infection in an individual homozygous for CCR5▵32

    loannis Theodorou;Laurence Meyer;Magdalena Magierowska;Christine Katlama

  • When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study

    Lauren E Cain;Roger Logan;James M Robins;Jonathan A C Sterne

  • The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2

    John J. Zone;Ted B. Taylor;Laurence J. Meyer;Marta J. Petersen

  • Harmonizing Genetic Ancestry and Self-identified Race/Ethnicity in Genome-wide Association Studies

    Huaying Fang;Huaying Fang;Qin Hui;Qin Hui;Julie Lynch;Julie Lynch;Jacqueline Honerlaw

  • Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.

    Laurence Meyer;Magdalena Magierowska;Jean-Baptiste Hubert;Christine Rouzioux

  • Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load

    Paul J. McLaren;Paul J. McLaren;Cedric Coulonges;István Bartha;István Bartha;Tobias L. Lenz

  • Weak anti-HIV CD8+ T-cell effector activity in HIV primary infection

    Marc Dalod;Marion Dupuis;Jean-Christophe Deschemin;Cécile Goujard

  • HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.

    Cécile Goujard;Isabelle Girault;Christine Rouzioux;Camille Lécuroux

  • Purine Overproduction in Man Associated with Increased Phosphoribosylpyrophosphate Synthetase Activity

    Michael A. Becker;Laurence J. Meyer;Alexander W. Wood;J. Edwin Seegmiller

  • Gout with purine overproduction due to increased phosphoribosylpyrophosphate synthetase activity

    Michael A. Becker;Laurence J. Meyer;J.Edwin Seegmiller

  • HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time.

    Jade Ghosn;Isabelle Pellegrin;Cécile Goujard;Christiane Deveau

  • Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy

    Nicole Ngo-Giang-Huong;Christiane Deveau;Isabelle Da Silva;Isabelle Pellegrin

  • Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France.

    Marie-Laure Chaix;Diane Descamps;Martine Harzic;Véronique Schneider

  • The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

    David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö

  • French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002.

    Diane Descamps;Marie-Laure Chaix;Patrice André;Véronique Brodard

Frequent Co-Authors

Lisa A. Cannon-Albright
Lisa A. Cannon-Albright University of Utah
Faroudy Boufassa
Faroudy Boufassa University of Paris-Saclay
Marie-Laure Chaix
Marie-Laure Chaix Université Paris Cité
David E. Goldgar
David E. Goldgar University of Utah
Mark H. Skolnick
Mark H. Skolnick Myriad Genetics (Germany)
Caroline Sabin
Caroline Sabin University College London
Andrew N. Phillips
Andrew N. Phillips University College London
Jade Ghosn
Jade Ghosn Hôpital Bichat - Claude-Bernard (Hôpitaux Universitaires Paris Nord Val de Seine)
Kholoud Porter
Kholoud Porter University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology opens doors to diverse careers in healthcare, research, and information management. For those interested in the administrative side of health services, pursuing a health information management job description and salary can provide valuable insights into this growing field. Health Information Managers play a crucial role in organizing and securing patient data, ensuring health systems run smoothly.

To enter this profession, many opt for a cahiim accredited him degree online. These programs ensure graduates meet industry standards and are well-prepared for certification and employment. The flexibility of accredited online degrees allows students to balance study with work or other commitments.

For those focused on quicker qualification, an accelerated medical billing and coding certificate online offers a streamlined path into healthcare administration. These certificates provide essential skills to manage billing systems, an integral part of healthcare operations.

Additionally, it’s useful to explore the range of medical degrees online available. Many health-related degrees can now be completed remotely, broadening access and career options for microbiology graduates looking to expand their expertise.

Best Scientists Citing Laurence Meyer

Trending Scientists

Recently Published Articles